Are the Days of Unfettered Pharmaceutical Pricing Gone?

Jack Bailey, President of GlaxoSmithKline Plc’s U.S. Pharmaceuticals, is working on bringing new drugs to market as efficiently as possible and says the days of unfettered pricing are done. Read more here. (Source: Cynthia Koons, Bloomberg Business, 2/11/16)

You might also be interested in:

Clarivate and Evidence Partners Team Up to promote DistillerSR… 02/03/2022
OM1 Launches Real-World Data Network for Neuroscience and… 03/31/2022
Syntropy and UCI Unite in 5-Year RWD Collaboration to Improve… 10/13/2021
GlobalData Plc: Big Data Crucial for Business Strategy Across… 05/18/2022
Evidence Partners and Clarivate Form Channel Partnership to… 02/01/2022
COMPASS Pathways and partners launch The Centre for Mental… 03/28/2022
Public Health and Pharmacy Professor Reviews Recent… 09/21/2021